Krishna Institute of Medical Sciences Limited (NSE:KIMS)
India flag India · Delayed Price · Currency is INR
726.00
-0.15 (-0.02%)
Nov 12, 2026, 3:29 PM IST

NSE:KIMS Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
2,1242,4143,8453,1003,3633,327
Depreciation & Amortization
3,7782,7581,7031,4021,245701.16
Other Amortization
7474696347.525.57
Loss (Gain) From Sale of Assets
195-109-4-6.127.17
Loss (Gain) From Sale of Investments
-59-5-48-18-11.83-95.1
Loss (Gain) on Equity Investments
-32-26-3--
Provision & Write-off of Bad Debts
13497130-14-115.4344.57
Other Operating Activities
1,2911,296997523491.22-45.29
Change in Accounts Receivable
-2,196-1,685-934-403-628.1-232.74
Change in Inventory
-393-329-133-6664.7-123.42
Change in Accounts Payable
1,707974620502-410.83101.18
Change in Other Net Operating Assets
-735-465-322124281.42-489.7
Operating Cash Flow
5,7125,1085,8185,2124,3213,240
Operating Cash Flow Growth
-7.92%-12.20%11.63%20.62%33.35%-8.97%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-13,287-14,279-10,089-6,473-5,745-1,703
Sale of Property, Plant & Equipment
301504721426.33.18
Cash Acquisitions
---1,757--1,477-11.3
Divestitures
----2-
Investment in Securities
-3,292-192398-8231,599-2,538
Other Investing Activities
1581138616125.54133.86
Investing Cash Flow
-17,621-14,517-11,162-7,526-5,469-4,115

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
-1,962288714--
Long-Term Debt Issued
-13,4238,4874,5933,8941,240
Total Debt Issued
11,76415,3858,7755,3073,8941,240
Short-Term Debt Repaid
-----399.51-625
Long-Term Debt Repaid
--2,780-968-500-2,273-1,805
Lease Payments
-834-685-131-323-262.18-95.48
Total Debt Repaid
-12,516-2,780-968-500-2,673-2,430
Net Debt Issued (Repaid)
-75212,6057,8074,8071,221-1,190
Issuance of Common Stock
14,756----1,917
Other Financing Activities
-2,374-3,202-2,376-2,640-1,024-116.73
Financing Cash Flow
11,6309,4035,4312,167196.42609.99

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
--4-1,3110.01
Net Cash Flow
-279-691-147359.77-264.95

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-7,575-9,171-4,271-1,261-1,4241,537
Free Cash Flow Growth
------41.23%
Free Cash Flow Margin
-16.48%-23.49%-14.07%-5.05%-6.48%9.31%
Free Cash Flow Per Share
-18.65-22.92-10.67-3.15-3.563.87
Levered Free Cash Flow
-10,047-11,282-4,730-2,238-2,3931,303
Unlevered Free Cash Flow
-8,372-10,052-4,176-1,948-2,2101,403
Free Cash Flow After Leases
-8,409-9,856-4,402-1,584-1,6871,442

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
2,3612,1311,498829337.43116.72
Cash Income Tax Paid
1,7341,5101,4141,402972.351,269
Change in Working Capital
-1,617-1,505-769157-692.81-744.68